Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial

Background: Previous research suggested that Chinese Medicine (CM) Formula Huashibaidu granule might shorten the disease course in coronavirus disease 2019 (COVID-19) patients. This research aimed to investigate the early treatment effect of Huashibaidu granule in well-managed patients with mild COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chen, Li, Li, Yang, Wei, Lv, Wenliang, Wang, Jian, Guo, Jing, Dong, Yu, Shi, Nannan, Lu, Cheng, Li, Zhiqiang, Shi, Zhan, Chen, Renbo, Huo, Ruili, Che, Qianzi, Tian, Yaxin, Xiang, Xinghua, Zhou, Junhui, Bian, Yongjun, Chen, Suping, Chen, Yang, Chen, Yingying, Cong, Xiaodong, Dong, Guoju, Hu, Lijie, Jiang, Jianxin, Leng, Luxing, Li, Bin, Li, Dongxu, Li, Hao, Li, Jing, Qi, Wensheng, Miao, Qing, Shi, Huaxin, Shi, Jiaheng, Wang, Bing, Wang, Gang, Wang, Wei, Xian, Yongyue, Xie, Xiaolei, Xu, Chunyan, Xu, Ming, Yan, Bei, Yang, Jinliang, Zhang, Li, Zhou, Zhenqi, Zhu, Haoning, Xiong, Yibai, Liu, Bin, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481869/
https://www.ncbi.nlm.nih.gov/pubmed/34604251
http://dx.doi.org/10.3389/fmed.2021.696976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481869/
https://www.ncbi.nlm.nih.gov/pubmed/34604251
http://dx.doi.org/10.3389/fmed.2021.696976

Ejemplares similares